Article
Genomic landscape of CD34+ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers.
Proceedings of the National Academy of Sciences of the United States of America - 10 Jun 2014
Xu Lan, Gu Zhao-Hui, Li Yang, Zhang Jin-Li, Chang Chun-Kang, Pan Chun-Ming, Shi Jing-Yi, Shen Yang, Chen Bing, Wang Yue-Ying, Jiang Lu, Lu Jing, Xu Xin, Tan Jue-Ling, Chen Yu, Wang Sheng-Yue, Li Xiao, Chen Zhu, Chen Sai-Juan
Abstract excerpt
Myelodysplastic syndrome (MDS) includes a group of diseases characterized by dysplasia of bone marrow myeloid lineages with ineffective hematopoiesis and frequent evolution to acute myeloid leukemia (AML). Whole-genome sequencing was performed in CD34(+) hematopoietic stem/progenitor cells (HSPCs) from eight cases of refractory anemia with excess blasts (RAEB), the high-risk subtype of MDS. The nucleotide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
